The Changing Landscape of New Approach Methodologies
Now more than ever, NAMs need to be considered a core aspect of modern drug…
The Changing Landscape of New Approach Methodologies
Now more than ever, NAMs need to be considered a core aspect of modern drug development – and scientists, decision-makers, regulators and governments must keep pace with this evolving landscape to ensure they are equipped to deliver the next-generation of therapies. The post The Changing Landscape of New Approach Methodologies appeared first on MedCity News.
Trump and Kennedy Seek To Relax Safeguards for AI Healthcare Tools
Paul Boyer, a psychotherapist for Kaiser Permanente in Oakland, California, is experiencing the AI revolution firsthand. He’s a little underwhelmed. The health giant has rolled out a new suite of note-taking software, made by healthcare AI pioneer Abridge, intended to summarize a patient’s visit at supersonic speed. For many clinicians, the technology soothes one of…
RFK Jr. Swaps Vaccine Talk for Healthy Foods and Reading to Tots in Push To Woo Voters
TOLEDO, Ohio — The little boy, dressed in a Toy Story sweatshirt, wrapped himself around the nation’s health secretary. “What do you guys want to be when you grow up?” Health and Human Services Secretary Robert F. Kennedy Jr. asked a carpet full of preschoolers. “A dinosaur!” the boy replied, squeezing tighter. Just weeks ago,…
How will Europe’s economies compare to the US by 2030?
That is the question Luis Garicano asks in his recent post. He relies on projections from the 2025 IMF World Economic Outlook. On the positive side, Eastern European countries’ economies are likely to converge with the US. While we have spent a decade complaining about Europe’s stagnation, a real positive convergence story has been unfolding…
New Podcast on Primary Care
This is one of those “Coming Soon” announcements. I spent the weekend with the wonderful gang from what I affectionately call Camp Claudia Cult, a group of mostly Californian policy wonks led by Claudia Williams, who these days is at the UC Berkeley School of public health. As you may have noticed I’ve been spending…
How Healthcare Leaders are Reacting to the White House’s Proposed Fertility Benefit Rule
Healthcare leaders are divided over the Trump administration’s proposed rule to expand employer-sponsored fertility benefits, with some praising broader access and others saying it falls short of guaranteeing comprehensive coverage. The post How Healthcare Leaders are Reacting to the White House’s Proposed Fertility Benefit Rule appeared first on MedCity News.
Health Leaders Join Forces to Launch Women’s Health AI Consortium
The initiative seeks to boost confidence among women and healthcare providers in AI tools
Inviting Investors and Corporate Business Development Leaders to Bullseye
This year, we are hosting a new event called Bullseye: Targeting Healthier Outcomes & Returns on July 23 in Chicago. It’s invitation-only and exclusively for healthcare investors and corporate business development leads. Join the waitlist for a chance to be in the room with your peers. The post Inviting Investors and Corporate Business Development Leaders…
Sanford Health Continues M&A Push with North Memorial Health Deal
Sanford Health signed a deal to acquire North Memorial Health, which could be its long-sought entry into the Twin Cities market. The move is the latest in a series of expansion efforts for the South Dakota-based health system. The post Sanford Health Continues M&A Push with North Memorial Health Deal appeared first on MedCity News.
Bristol Myers, Hengrui Pharma Team Up in Global Drug Research Pact That Could Top $15B
Bristol Myers Squibb is paying $600 million up front to begin a 13-drug collaboration with Hengrui Pharma spanning oncology, hematology, and immunology. That tops a 12-drug pact GSK inked last year with Hengrui, a China-based company that has global growth ambitions. The post Bristol Myers, Hengrui Pharma Team Up in Global Drug Research Pact That…
